pharma · Elderly AML Patients · Menkes Syndrome
Kunming Hope of
Kunming Hope of Health Hospital
Kunming Hope of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Elderly AML Patients, Menkes Syndrome. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent rec
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 8
- Patents
- 0
Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
Phase 3 · other · Elderly AML Patients
Experimental: Venetoclax in combination with Decitabine (+-sorafenib) for Elderly AML Patients is a Phase 3 program (other) at Kunming Hope of Health Hospital with 1 ClinicalTrials.gov record(s).
Internal code SHEN-PJ-KE-2023-223
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Kunming Hope of Health Hospital
- Phase
- Phase 3
- Modality
- other
- Indication
- Elderly AML Patients
- Status
- active
- Trials
- 1